Julián Isla

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Dravet syndrome is a rare form of epilepsy largely refractory to current antiepileptic medications. The only precedents of randomized placebo-controlled trials in Dravet syndrome are the two small trials that led to the approval of stiripentol. With the arrival of new clinical trials for Dravet syndrome, we sought to determine the characteristics of the(More)
  • 1